Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children


Autoria(s): Belo, V. A.; Souza-Costa, D. C.; Luizon, M. R.; Lanna, C. M. M.; Carneiro, P. C.; Izidoro-Toledo, T. C.; Ferraz, K. C.; Tanus-Santos, J. E.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

Objective: Matrix metalloproteinase-9 (MMP-9) is involved in the atherosclerotic process and functional polymorphisms in the MMP-9 gene affect MMP-9 expression/activity, and are associated with cardiovascular diseases. However, no study has tested the hypothesis that functional MMP-9 polymorphisms could affect MMP-9 levels in obese children. We investigated whether three MMP-9 gene polymorphisms (C-1562T (rs3918242), 90(CA)((14-24)) (rs2234681) and Q279R (rs17576)), or haplotypes, affect MMP-9 levels in obese children. Methods: We studied 175 healthy control children and 127 obese children. Plasma MMP-9, tissue inhibitor of MMPs (TIMP)-1 and adiponectin concentrations were measured using enzyme-linked immunosorbent assay. Results: We found similar MMP-9 genotypes, allelic and haplotypes distributions in the two study groups (P > 0.05). However, we found lower plasma MMP-9 concentrations in obese subjects carrying the CC or the QQ genotypes for the C-1562T and the Q279R polymorphisms, respectively, in obese children compared with children with the other genotypes, or with non-obese children with the same genotypes (all P < 0.05). Moreover, we found lower MMP-9 levels and lower MMP-9/TIMP-1 ratios (which reflect net MMP-9 activity) in obese children carrying the H2 haplotype (which combines the C, H and Q alleles for the three polymorphisms, respectively) when compared with obese children carrying the other haplotypes, or with non-obese children carrying the same haplotype (P < 0.05). Conclusions: Our findings show that MMP-9 genotypes and haplotypes affect MMP-9 levels in obese children and adolescents, and suggest that genetic factors may modify relevant pathogenetic mechanisms involved in the development of cardiovascular complications associated with obesity in childhood. International Journal of Obesity (2012) 36, 69-75; doi:10.1038/ijo.2011.169; published online 16 August 2011

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

IMEPEN Foundation at Juiz de Fora

Identificador

INTERNATIONAL JOURNAL OF OBESITY, LONDON, v. 36, n. 1, pp. 69-75, JAN, 2012

0307-0565

http://www.producao.usp.br/handle/BDPI/42622

10.1038/ijo.2011.169

http://dx.doi.org/10.1038/ijo.2011.169

Idioma(s)

eng

Publicador

NATURE PUBLISHING GROUP

LONDON

Relação

INTERNATIONAL JOURNAL OF OBESITY

Direitos

restrictedAccess

Copyright NATURE PUBLISHING GROUP

Palavras-Chave #MATRIX METALLOPROTEINASE-9 #CHILDHOOD OBESITY #POLYMORPHISMS #HAPLOTYPE #FUNCTIONAL POLYMORPHISM #MATRIX METALLOPROTEINASES #CARDIOVASCULAR-DISEASE #TISSUE INHIBITOR #HEALTHY-SUBJECTS #ATHEROSCLEROSIS #ADOLESCENTS #PROMOTER #HYPERTENSION #ASSOCIATION #ENDOCRINOLOGY & METABOLISM #NUTRITION & DIETETICS
Tipo

article

original article

publishedVersion